Alström syndrome
General Information (adopted from Orphanet):
Synonyms, Signs: |
ALMS ALSS |
Number of Symptoms | 249 |
OrphanetNr: | 64 |
OMIM Id: |
203800
|
ICD-10: |
E66.0 H35.5 |
UMLs: |
C0268425 |
MeSH: |
D056769 |
MedDRA: |
10068783 |
Snomed: |
63702009 |
Prevalence, inheritance and age of onset:
Prevalence: | <= 0.9 of 100 000 - PMID: 26229500 [IBIS] |
Inheritance: |
Monogenic Autosomal recessive - PMID: 17594715 [IBIS] |
Age of onset: |
Neonatal Infancy Childhood Adolescent Adult - PMID: 26229500 [IBIS] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
Rare genetic diabetes mellitus
-Rare genetic disease Rare insulin-independent diabetes mellitus -Rare endocrine disease Syndrome associated with dilated cardiomyopathy -Rare cardiac disease -Rare genetic disease Syndromic genetic deafness -Rare developmental defect during embryogenesis -Rare genetic disease -Rare otorhinolaryngologic disease Syndromic obesity -Rare developmental defect during embryogenesis -Rare endocrine disease -Rare genetic disease Syndromic retinitis pigmentosa -Rare eye disease -Rare genetic disease |
Comment:
Alstrom syndrome (ALMS) is caused by homozygous or compound heterozygous mutation in the ALMS1 gene. (OMIM) Alstrom Syndrome is a rare, multisystemic genetic disorder exhibiting cone–rod dystrophy (early nystagmus, blindness), hearing loss, obesity, insulin resistance and hyperinsulinemia, type 2 diabetes mellitus, dilated cardiomyopathy, and progressive hepatic and renal dysfunction. The clinical features, time of onset, and severity can vary greatly among and within families. Mutations in ALMS1 that cause Alstrom Syndrome are clustered and exhibit relatively few genotype - phenotype correlations. (PMID:17940554) |
Symptom Information:
|
(HPO:0007703) | Abnormality of retinal pigmentation | 2231654; 9663233; 17940554 | IBIS | 21 / 7739 | ||
|
(HPO:0011516) | Achromatopsia | 22876109 | IBIS | 5 / 7739 | ||
|
(HPO:0012330) | Pyelonephritis | 18154657 | IBIS | 7 / 7739 | ||
|
(HPO:0005576) | Tubulointerstitial fibrosis | 26229500; 23188138; 9066877; 17940554 | IBIS | 32 / 7739 | ||
|
(HPO:0000044) | Hypogonadotrophic hypogonadism | 23652376; 23188138 | IBIS | 56 / 7739 | ||
|
(HPO:0000789) | Infertility | Occasional [Orphanet] | 26229500; 18154657 | IBIS | 74 / 7739 | |
|
(HPO:0000858) | Menstrual irregularities | 22876109; 18154657; 17940554 | IBIS | 42 / 7739 | ||
|
(HPO:0000147) | Polycystic ovaries | Occasional [Orphanet] | 26229500; 22876109 | IBIS | 18 / 7739 | |
|
(HPO:0008661) | Urethral stenosis | Occasional [Orphanet] | 2231654 | IBIS | 9 / 7739 | |
|
(HPO:0000138) | Ovarian cyst | Occasional [Orphanet] occasional [HPO] | 26229500; 22876109; 18154657; 17940554 | IBIS | 25 / 7739 | |
|
(HPO:0010955) | Dilatation of the bladder | 2231654 | IBIS | 2 / 7739 | ||
|
(HPO:0000796) | Urethral obstruction | 18154657; 17940554 | IBIS | 3 / 7739 | ||
|
(HPO:0011130) | Abnormality of renal calyx morphology | 18154657 | IBIS | 2 / 7739 | ||
|
(HPO:0000123) | Nephritis | 8636816 | IBIS | 18 / 7739 | ||
|
(HPO:0100820) | Glomerulopathy | Occasional [Orphanet] | 23188138 | IBIS | 46 / 7739 | |
|
(HPO:0012213) | Decreased glomerular filtration rate | 2231654; 23652376 | IBIS | 21 / 7739 | ||
|
(HPO:0000012) | Urinary urgency | 17594715; 18154657; 17940554 | IBIS | 35 / 7739 | ||
|
(HPO:0100817) | Renovascular hypertension | Occasional [Orphanet] | 9066877 | IBIS | 9 / 7739 | |
|
(HPO:0000029) | Testicular atrophy | 17940554 | IBIS | 13 / 7739 | ||
|
(HPO:0000134) | Female hypogonadism | 17940554 | IBIS | 5 / 7739 | ||
|
(HPO:0000020) | Urinary incontinence | 17594715; 2231654; 23652376; 17940554 | IBIS | 75 / 7739 | ||
|
(HPO:0000072) | Hydroureter | 18154657 | IBIS | 146 / 7739 | ||
|
(HPO:0008669) | Abnormal spermatogenesis | 9066877 | IBIS | 11 / 7739 | ||
|
(HPO:0012227) | Urethral stricture | 17940554 | IBIS | 5 / 7739 | ||
|
(HPO:0000010) | Recurrent urinary tract infections | 17594715; 2231654; 18154657; 17940554 | IBIS | 56 / 7739 | ||
|
(HPO:0000798) | Oligospermia | 17940554 | IBIS | 13 / 7739 | ||
|
(HPO:0000077) | Abnormality of the kidney | 26229500; 24049434; 23188138; 18154657; 9663233 | IBIS | 73 / 7739 | ||
|
(HPO:0000093) | Proteinuria | 18154657 | IBIS | 169 / 7739 | ||
|
(HPO:0000083) | Renal insufficiency | Frequent [IBIS] Occasional [Orphanet] | 26229500; 2231654; 23188138; 18154657; 9066877; 9409865; 17940554 | IBIS | 232 / 7739 | |
|
(HPO:0003076) | Glycosuria | 2231654; 23652376; 9066877 | IBIS | 32 / 7739 | ||
|
(HPO:0000050) | Hypoplastic male external genitalia | 9409865; 17940554 | IBIS | 10 / 7739 | ||
|
(HPO:0000103) | Polyuria | Occasional [Orphanet] | 9066877 | IBIS | 60 / 7739 | |
|
(HPO:0012211) | Abnormal renal physiology | 2231654 | IBIS | 23 / 7739 | ||
|
(HPO:0000112) | Nephropathy | 23652376; 17940554 | IBIS | 92 / 7739 | ||
|
(HPO:0012592) | Albuminuria | 2231654; 23652376 | IBIS | 6 / 7739 | ||
|
(HPO:0000135) | Hypogonadism | 26229500; 24049434; 23188138; 18154657 | IBIS | 89 / 7739 | ||
|
(HPO:0000815) | Hypergonadotropic hypogonadism | 18154657; 8636816 | IBIS | 48 / 7739 | ||
|
(HPO:0000026) | Male hypogonadism | 11941369; 2231654; 23652376; 22876109; 9066877; 17940554 | IBIS | 20 / 7739 | ||
|
(HPO:0000092) | Tubular atrophy | 9066877 | IBIS | 28 / 7739 | ||
|
(HPO:0000016) | Urinary retention | 17594715; 18154657; 17940554 | IBIS | 7 / 7739 | ||
|
(HPO:0000311) | Round face | Occasional [Orphanet] | 18154657; 17940554 | IBIS | 104 / 7739 | |
|
(HPO:0006349) | Agenesis of permanent teeth | 17940554 | IBIS | 13 / 7739 | ||
|
(HPO:0004438) | Hyperostosis frontalis interna | 2231654; 18154657; 9409865; 17940554 | IBIS | 2 / 7739 | ||
|
(HPO:0000164) | Abnormality of the teeth | 18154657 | IBIS | 291 / 7739 | ||
|
(HPO:0002293) | Alopecia of scalp | 2231654 | IBIS | 9 / 7739 | ||
|
(HPO:0002837) | Recurrent bronchitis | 17594715; 17940554 | IBIS | 21 / 7739 | ||
|
(HPO:0006304) | Widely-spaced incisors | 17940554 | IBIS | 2 / 7739 | ||
|
(HPO:0011069) | Increased number of teeth | 17940554 | IBIS | 39 / 7739 | ||
|
(HPO:0000470) | Short neck | 2231654 | IBIS | 345 / 7739 | ||
|
(HPO:0000490) | Deeply set eye | Occasional [Orphanet] | 18154657; 17940554 | IBIS | 131 / 7739 | |
|
(HPO:0000230) | Gingivitis | 17940554 | IBIS | 31 / 7739 | ||
|
(HPO:0000670) | Carious teeth | 9409865 | IBIS | 145 / 7739 | ||
|
(HPO:0011073) | Abnormality of dental color | 17940554 | IBIS | 24 / 7739 | ||
|
(HPO:0000246) | Sinusitis | 18154657; 17940554 | IBIS | 73 / 7739 | ||
|
(HPO:0000540) | Hypermetropia | 22876109; 9409865 | IBIS | 99 / 7739 | ||
|
(HPO:0000630) | Abnormality of retinal arteries | 9409865 | IBIS | 1 / 7739 | ||
|
(HPO:0000602) | Ophthalmoplegia | 22876109 | IBIS | 56 / 7739 | ||
|
(HPO:0000666) | Horizontal nystagmus | 9409865; 8636816 | IBIS | 32 / 7739 | ||
|
(HPO:0000648) | Optic atrophy | 23652376; 3766665 | IBIS | 238 / 7739 | ||
|
(HPO:0000523) | Subcapsular cataract | 18154657 | IBIS | 12 / 7739 | ||
|
(HPO:0001133) | Constriction of peripheral visual field | 22876109 | IBIS | 33 / 7739 | ||
|
(HPO:0007702) | Pigmentary retinal deposits | 3766665 | IBIS | 5 / 7739 | ||
|
(HPO:0000572) | Visual loss | Frequent [Orphanet] | 8636816 | IBIS | 272 / 7739 | |
|
(HPO:0012043) | Pendular nystagmus | 18154657; 9409865 | IBIS | 11 / 7739 | ||
|
(HPO:0000639) | Nystagmus | Very frequent [IBIS] Frequent [Orphanet] | 26229500; 2231654; 24049434; 23188138; 22876109; 18154657; 9409865; 8636816; 9663233; 17940554 | IBIS | 555 / 7739 | |
|
(HPO:0007793) | Granular macular appearance | 24049434; 3766665 | IBIS | 2 / 7739 | ||
|
(HPO:0000580) | Pigmentary retinopathy | 3766665; 9409865 | IBIS | 49 / 7739 | ||
|
(HPO:0000543) | Optic disc pallor | 9409865; 8636816; 9663233; 17940554 | IBIS | 67 / 7739 | ||
|
(HPO:0000546) | Retinal degeneration | 26229500; 9066877 | IBIS | 61 / 7739 | ||
|
(HPO:0007722) | Retinal pigment epithelial atrophy | 24049434 | IBIS | 10 / 7739 | ||
|
(HPO:0000488) | Retinopathy | 17594715; 23652376; 9409865 | IBIS | 75 / 7739 | ||
|
(HPO:0000662) | Nyctalopia | 22876109; 18154657 | IBIS | 92 / 7739 | ||
|
(HPO:0000556) | Retinal dystrophy | Very frequent [Orphanet] | 22876109; 18154657; 9409865 | IBIS | 65 / 7739 | |
|
(HPO:0000518) | Cataract | Frequent [Orphanet] | 23652376; 18154657; 17940554 | IBIS | 454 / 7739 | |
|
(HPO:0000486) | Strabismus | 22876109 | IBIS | 576 / 7739 | ||
|
(HPO:0000608) | Macular degeneration | 24049434 | IBIS | 36 / 7739 | ||
|
(HPO:0000618) | Blindness | Very frequent [IBIS] Frequent [Orphanet] | 26229500; 17594715; 2231654; 26441796; 23188138; 18154657; 17940554 | IBIS | 124 / 7739 | |
|
(HPO:0000548) | Cone/cone-rod dystrophy | Very frequent [IBIS] | 26229500; 17594715; 26441796; 24049434; 23188138; 22876109; 18154657; 9409865; 8636816; 9663233; 17940554 | IBIS | 47 / 7739 | |
|
(HPO:0007898) | Exudative retinopathy | 18154657 | IBIS | 3 / 7739 | ||
|
(HPO:0000505) | Visual impairment | Very frequent [IBIS] Frequent [Orphanet] | 2231654; 24049434; 23188138; 22876109; 9066877 | IBIS | 297 / 7739 | |
|
(HPO:0000613) | Photophobia | Very frequent [IBIS] Frequent [Orphanet] | 26229500; 2231654; 24049434; 23188138; 22876109; 18154657; 9409865; 8636816; 9663233; 17940554 | IBIS | 158 / 7739 | |
|
(HPO:0007787) | Posterior subcapsular cataract | 2231654; 9409865; 8636816 | IBIS | 20 / 7739 | ||
|
(HPO:0000510) | Rod-cone dystrophy | 26441796; 23652376; 18154657 | IBIS | 266 / 7739 | ||
|
(HPO:0007703) | Abnormality of retinal pigmentation | 9409865 | IBIS | 21 / 7739 | ||
|
(HPO:0000533) | Chorioretinal atrophy | 3766665 | IBIS | 24 / 7739 | ||
|
(HPO:0007843) | Attenuation of retinal blood vessels | 24049434; 3766665; 9663233; 17940554 | IBIS | 25 / 7739 | ||
|
(HPO:0010544) | Vertical nystagmus | 23652376 | IBIS | 5 / 7739 | ||
|
(HPO:0009894) | Thickened ears | 18154657 | IBIS | 1 / 7739 | ||
|
(HPO:0000389) | Chronic otitis media | Frequent [Orphanet] | 18154657; 9409865 | IBIS | 64 / 7739 | |
|
(HPO:0000407) | Sensorineural hearing impairment | Very frequent [IBIS] Very frequent [Orphanet] | 26229500; 17594715; 2231654; 24049434; 9066877; 8636816; 9663233; 17940554 | IBIS | 524 / 7739 | |
|
(HPO:0000403) | Recurrent otitis media | 9409865; 17940554 | IBIS | 61 / 7739 | ||
|
(HPO:0000408) | Progressive sensorineural hearing impairment | Frequent [IBIS] | 26229500; 26441796; 23188138; 22876109; 18154657; 9409865; 17940554 | IBIS | 28 / 7739 | |
|
(HPO:0005101) | High-frequency hearing impairment | 18154657 | IBIS | 16 / 7739 | ||
|
(HPO:0000405) | Conductive hearing impairment | 18154657; 9409865 | IBIS | 164 / 7739 | ||
|
(HPO:0008625) | Severe sensorineural hearing impairment | Very frequent [Orphanet] hallmark [HPO] | 17594715; 2231654 | IBIS | 150 / 7739 | |
|
(HPO:0001757) | High-frequency sensorineural hearing impairment | 9409865; 17940554 | IBIS | 7 / 7739 | ||
|
(HPO:0000365) | Hearing impairment | 2231654; 23652376; 23188138 | IBIS | 539 / 7739 | ||
|
(HPO:0000388) | Otitis media | Frequent [Orphanet] | 26441796 | IBIS | 28 / 7739 | |
|
(HPO:0002591) | Polyphagia | 26441796; 18154657; 17940554 | IBIS | 25 / 7739 | ||
|
(HPO:0009830) | Peripheral neuropathy | 23652376 | IBIS | 206 / 7739 | ||
|
(HPO:0100543) | Cognitive impairment | Occasional [Orphanet] | 26229500; 23188138 | IBIS | 230 / 7739 | |
|
(HPO:0001263) | Global developmental delay | Frequent [IBIS] | 26229500; 11941369; 23188138; 22876109; 18154657; 9409865; 9409865; 8636816 | IBIS | 853 / 7739 | |
|
(HPO:0001328) | Specific learning disability | Occasional [Orphanet] | 18154657 | IBIS | 114 / 7739 | |
|
(HPO:0000708) | Behavioral abnormality | 26441796 | IBIS | 212 / 7739 | ||
|
(HPO:0010863) | Receptive language delay | 26441796 | IBIS | 2 / 7739 | ||
|
(HPO:0000734) | Disinhibition | 26441796 | IBIS | 13 / 7739 | ||
|
(HPO:0002069) | Generalized tonic-clonic seizures | 23188138 | IBIS | 96 / 7739 | ||
|
(HPO:0002370) | Poor coordination | 26441796 | IBIS | 15 / 7739 | ||
|
(HPO:0012432) | Chronic fatigue | 2231654 | IBIS | 5 / 7739 | ||
|
(HPO:0002360) | Sleep disturbance | 26229500; 18154657; 17940554 | IBIS | 113 / 7739 | ||
|
(HPO:0000750) | Delayed speech and language development | 26441796; 23188138 | IBIS | 197 / 7739 | ||
|
(HPO:0007010) | Poor fine motor coordination | 26441796 | IBIS | 4 / 7739 | ||
|
(HPO:0001249) | Intellectual disability | Occasional [Orphanet] | 24049434 | IBIS | 1089 / 7739 | |
|
(HPO:0001251) | Ataxia | 17940554 | IBIS | 413 / 7739 | ||
|
(HPO:0011210) | EEG with occipital slowing | 23652376 | IBIS | 1 / 7739 | ||
|
(HPO:0001336) | Myoclonus | 17594715 | IBIS | 115 / 7739 | ||
|
(HPO:0010829) | Impaired temperature sensation | 23652376 | IBIS | 5 / 7739 | ||
|
(HPO:0002495) | Impaired vibratory sensation | 23652376 | IBIS | 26 / 7739 | ||
|
(HPO:0001270) | Motor delay | Occasional [Orphanet] | 26441796 | IBIS | 322 / 7739 | |
|
(HPO:0001250) | Seizures | Occasional [Orphanet] | 23652376; 23652376; 23188138 | IBIS | 1245 / 7739 | |
|
(HPO:0001959) | Polydipsia | 9066877 | IBIS | 43 / 7739 | ||
|
(HPO:0002121) | Absence seizures | Occasional [IBIS] | 26229500; 17594715; 23188138; 18154657; 17940554 | IBIS | 62 / 7739 | |
|
(HPO:0000729) | Autistic behavior | 17940554 | IBIS | 27 / 7739 | ||
|
(HPO:0000771) | Gynecomastia | 23188138; 9409865; 9663233; 17940554 | IBIS | 53 / 7739 | ||
|
(HPO:0000821) | Hypothyroidism | Frequent [IBIS] Occasional [Orphanet] | 24049434; 26229500; 11941369; 2231654; 23188138; 22876109; 18154657; 9409865; 9409865; 17940554 | IBIS | 141 / 7739 | |
|
(HPO:0000826) | Precocious puberty | Occasional [Orphanet] | 9066877 | IBIS | 42 / 7739 | |
|
(HPO:0005978) | Type II diabetes mellitus | Very frequent [IBIS] Frequent [Orphanet] | 26229500; 11941369; 17594715; 2231654; 24049434; 23188138; 22876109; 18154657; 9066877; 9409865; 8636816; 9663233; 17940554 | IBIS | 68 / 7739 | |
|
(HPO:0000824) | Growth hormone deficiency | Frequent [IBIS] | 26229500; 23188138; 18154657; 8418611; 17940554 | IBIS | 56 / 7739 | |
|
(HPO:0010465) | Precocious puberty in females | 17940554 | IBIS | 1 / 7739 | ||
|
(HPO:0000873) | Diabetes insipidus | 23652376; 8556827; 9409865 | IBIS | 34 / 7739 | ||
|
(HPO:0012503) | Abnormality of the pituitary gland | 23652376 | IBIS | 2 / 7739 | ||
|
(HPO:0000823) | Delayed puberty | 17940554 | IBIS | 65 / 7739 | ||
|
(HPO:0000842) | Hyperinsulinemia | Frequent [Orphanet] | 26229500; 11941369; 17594715; 2231654; 24049434; 23188138; 22876109; 18154657; 8418611; 9066877; 9409865; 9663233; 17940554 | IBIS | 39 / 7739 | |
|
(HPO:0001831) | Short toe | 18154657; 17940554 | IBIS | 52 / 7739 | ||
|
(HPO:0002751) | Kyphoscoliosis | 2231654 | IBIS | 131 / 7739 | ||
|
(HPO:0001769) | Broad foot | 18154657; 17940554 | IBIS | 31 / 7739 | ||
|
(HPO:0005616) | Accelerated skeletal maturation | 18154657; 8418611; 9409865; 17940554 | IBIS | 46 / 7739 | ||
|
(HPO:0003368) | Abnormality of the femoral head | 2231654 | IBIS | 1 / 7739 | ||
|
(HPO:0003177) | Squared iliac bones | 2231654 | IBIS | 7 / 7739 | ||
|
(HPO:0002808) | Kyphosis | 26229500; 2231654; 23652376; 9409865; 17940554 | IBIS | 289 / 7739 | ||
|
(HPO:0004626) | Lumbar scoliosis | 17940554 | IBIS | 5 / 7739 | ||
|
(HPO:0009381) | Short finger | 18154657; 17940554 | IBIS | 45 / 7739 | ||
|
(HPO:0001763) | Pes planus | 26229500; 18154657; 17940554 | IBIS | 176 / 7739 | ||
|
(HPO:0002943) | Thoracic scoliosis | 17940554 | IBIS | 12 / 7739 | ||
|
(HPO:0002650) | Scoliosis | 26229500; 24049434; 23188138; 22876109; 18154657; 9409865; 9409865; 17940554 | IBIS | 705 / 7739 | ||
|
(HPO:0003270) | Abdominal distention | 9066877 | IBIS | 46 / 7739 | ||
|
(HPO:0002240) | Hepatomegaly | Occasional [Orphanet] | 17594715; 23652376; 9409865; 8636816; 9663233; 17940554 | IBIS | 467 / 7739 | |
|
(HPO:0002019) | Constipation | 18154657 | IBIS | 194 / 7739 | ||
|
(HPO:0001433) | Hepatosplenomegaly | 23652376; 17940554 | IBIS | 78 / 7739 | ||
|
(HPO:0002239) | Gastrointestinal hemorrhage | 17940554 | IBIS | 97 / 7739 | ||
|
(HPO:0001410) | Decreased liver function | 18154657 | IBIS | 59 / 7739 | ||
|
(HPO:0001392) | Abnormality of the liver | 26229500; 11941369; 24049434 | IBIS | 28 / 7739 | ||
|
(HPO:0001409) | Portal hypertension | Occasional [Orphanet] | 17594715; 18154657; 17940554 | IBIS | 39 / 7739 | |
|
(HPO:0001541) | Ascites | 23188138; 9066877 | IBIS | 94 / 7739 | ||
|
(HPO:0001399) | Hepatic failure | 17940554 | IBIS | 80 / 7739 | ||
|
(HPO:0001735) | Acute pancreatitis | 26229500; 18154657 | IBIS | 6 / 7739 | ||
|
(HPO:0002910) | Elevated hepatic transaminases | 17594715; 23188138; 18154657; 9066877; 9663233; 17940554 | IBIS | 158 / 7739 | ||
|
(HPO:0002249) | Melena | 9066877 | IBIS | 11 / 7739 | ||
|
(HPO:0001397) | Hepatic steatosis | Occasional [Orphanet] | 17594715; 23652376; 18154657; 9066877; 17940554 | IBIS | 75 / 7739 | |
|
(HPO:0002040) | Esophageal varix | 17594715; 9066877; 17940554 | IBIS | 23 / 7739 | ||
|
(HPO:0002020) | Gastroesophageal reflux | 18154657 | IBIS | 101 / 7739 | ||
|
(HPO:0002018) | Nausea | 9066877 | IBIS | 44 / 7739 | ||
|
(HPO:0001395) | Hepatic fibrosis | 26229500; 23188138; 9066877; 17940554 | IBIS | 67 / 7739 | ||
|
(HPO:0012115) | Hepatitis | 17940554 | IBIS | 24 / 7739 | ||
|
(HPO:0002028) | Chronic diarrhea | 18154657 | IBIS | 51 / 7739 | ||
|
(HPO:0002605) | Hepatic necrosis | 9066877 | IBIS | 6 / 7739 | ||
|
(HPO:0002013) | Vomiting | 23188138 | IBIS | 191 / 7739 | ||
|
(HPO:0001081) | Cholelithiasis | 23188138 | IBIS | 36 / 7739 | ||
|
(HPO:0001394) | Cirrhosis | Occasional [Orphanet] | 17594715; 23652376; 18154657; 9066877; 17940554 | IBIS | 102 / 7739 | |
|
(HPO:0001744) | Splenomegaly | Occasional [Orphanet] | 17594715; 23652376; 18154657; 9066877; 17940554 | IBIS | 337 / 7739 | |
|
(HPO:0002248) | Hematemesis | 9066877 | IBIS | 12 / 7739 | ||
|
(HPO:0001508) | Failure to thrive | 23188138 | IBIS | 454 / 7739 | ||
|
(HPO:0001956) | Truncal obesity | Very frequent [IBIS] Very frequent [Orphanet] | 26229500; 2231654; 24049434; 23188138; 9409865 | IBIS | 39 / 7739 | |
|
(HPO:0008897) | Postnatal growth retardation | 9409865 | IBIS | 113 / 7739 | ||
|
(HPO:0008915) | Childhood-onset truncal obesity | Frequent [IBIS] | 11941369; 17594715; 18154657; 17940554 | IBIS | 3 / 7739 | |
|
(HPO:0004322) | Short stature | Very frequent [Orphanet] | 26229500; 11941369; 2231654; 24049434; 23188138; 22876109; 18154657; 9409865; 9663233; 17940554 | IBIS | 1232 / 7739 | |
|
(HPO:0009937) | Facial hirsutism | 18154657 | IBIS | 4 / 7739 | ||
|
(HPO:0000962) | Hyperkeratosis | 26229500 | IBIS | 216 / 7739 | ||
|
(HPO:0000961) | Cyanosis | 9409865 | IBIS | 60 / 7739 | ||
|
(HPO:0000956) | Acanthosis nigricans | Frequent [IBIS] Frequent [Orphanet] | 26229500; 2231654; 24049434; 23188138; 22876109; 18154657; 9066877; 9409865; 8636816; 9663233; 17940554 | IBIS | 54 / 7739 | |
|
(HPO:0001072) | Thickened skin | 2231654; 17940554 | IBIS | 87 / 7739 | ||
|
(HPO:0000958) | Dry skin | 2231654 | IBIS | 152 / 7739 | ||
|
(HPO:0001596) | Alopecia | Occasional [Orphanet] | 23188138; 18154657; 9409865; 17940554 | IBIS | 162 / 7739 | |
|
(HPO:0000953) | Hyperpigmentation of the skin | 26229500; 2231654 | IBIS | 75 / 7739 | ||
|
(HPO:0009889) | Localized hirsutism | 18154657 | IBIS | 1 / 7739 | ||
|
(HPO:0001007) | Hirsutism | Occasional [Orphanet] occasional [HPO] | 26229500; 18154657; 17940554 | IBIS | 91 / 7739 | |
|
(HPO:0002292) | Frontal balding | 18154657; 17940554 | IBIS | 4 / 7739 | ||
|
(HPO:0008070) | Sparse hair | 17940554 | IBIS | 94 / 7739 | ||
|
(HPO:0001649) | Tachycardia | 8636816 | IBIS | 53 / 7739 | ||
|
(HPO:0001685) | Myocardial fibrosis | 23188138; 8636816 | IBIS | 30 / 7739 | ||
|
(HPO:0002621) | Atherosclerosis | 11941369; 9409865 | IBIS | 33 / 7739 | ||
|
(HPO:0001635) | Congestive heart failure | Occasional [Orphanet] | 26229500; 23188138; 18154657; 9409865; 9663233; 17940554 | IBIS | 232 / 7739 | |
|
(HPO:0011701) | Multifocal atrial tachycardia | 23188138 | IBIS | 7 / 7739 | ||
|
(HPO:0011705) | First degree atrioventricular block | 23188138 | IBIS | 13 / 7739 | ||
|
(HPO:0001706) | Endocardial fibroelastosis | 9663233 | IBIS | 20 / 7739 | ||
|
(HPO:0000822) | Hypertension | 23188138; 18154657; 9409865; 9409865; 17940554 | IBIS | 224 / 7739 | ||
|
(HPO:0001644) | Dilated cardiomyopathy | Frequent [IBIS] Frequent [Orphanet] | 26229500; 11941369; 24049434; 23188138; 23188138; 22876109; 18154657; 9409865; 8636816; 17940554 | IBIS | 141 / 7739 | |
|
(HPO:0001723) | Restrictive cardiomyopathy | 23188138 | IBIS | 22 / 7739 | ||
|
(HPO:0001643) | Patent ductus arteriosus | 9663233 | IBIS | 228 / 7739 | ||
|
(HPO:0001642) | Pulmonic stenosis | 9663233 | IBIS | 89 / 7739 | ||
|
(HPO:0001667) | Right ventricular hypertrophy | 8636816 | IBIS | 23 / 7739 | ||
|
(HPO:0001712) | Left ventricular hypertrophy | 8636816 | IBIS | 76 / 7739 | ||
|
(HPO:0001640) | Cardiomegaly | 9409865; 8636816 | IBIS | 81 / 7739 | ||
|
(HPO:0012250) | ST segment depression | 23188138 | IBIS | 7 / 7739 | ||
|
(HPO:0001698) | Pericardial effusion | 23188138 | IBIS | 20 / 7739 | ||
|
(HPO:0001701) | Pericarditis | 9409865 | IBIS | 13 / 7739 | ||
|
(HPO:0001711) | Abnormality of the left ventricle | 8636816 | IBIS | 22 / 7739 | ||
|
(HPO:0001973) | Autoimmune thrombocytopenia | 9409865 | IBIS | 18 / 7739 | ||
|
(HPO:0012200) | Abnormality of prothrombin | 17940554 | IBIS | 1 / 7739 | ||
|
(HPO:0001993) | Ketoacidosis | 23652376 | IBIS | 17 / 7739 | ||
|
(HPO:0011227) | Elevated C-reactive protein level | 23188138 | IBIS | 55 / 7739 | ||
|
(HPO:0002149) | Hyperuricemia | 2231654; 9409865 | IBIS | 37 / 7739 | ||
|
(HPO:0000855) | Insulin resistance | Frequent [Orphanet] | 26229500; 24049434; 23652376; 23188138; 22876109; 8418611; 8636816; 17940554 | IBIS | 32 / 7739 | |
|
(HPO:0003259) | Elevated serum creatinine | 18154657; 9066877 | IBIS | 31 / 7739 | ||
|
(HPO:0003074) | Hyperglycemia | 11941369; 23188138 | IBIS | 37 / 7739 | ||
|
(HPO:0003233) | Hypoalphalipoproteinemia | 18154657 | IBIS | 18 / 7739 | ||
|
(HPO:0002155) | Hypertriglyceridemia | Frequent [IBIS] Frequent [Orphanet] | 26229500; 17594715; 2231654; 24049434; 23188138; 18154657; 9409865; 9409865; 17940554 | IBIS | 67 / 7739 | |
|
(HPO:0003124) | Hypercholesterolemia | Frequent [Orphanet] | 23652376 | IBIS | 53 / 7739 | |
|
(HPO:0003155) | Elevated alkaline phosphatase | 18154657 | IBIS | 52 / 7739 | ||
|
(HPO:0003077) | Hyperlipidemia | Frequent [Orphanet] | 26229500; 11941369; 24049434; 23188138; 17940554 | IBIS | 37 / 7739 | |
|
(HPO:0003573) | Increased total bilirubin | 9663233 | IBIS | 10 / 7739 | ||
|
(HPO:0002206) | Pulmonary fibrosis | Occasional [Orphanet] | 23188138; 17940554 | IBIS | 51 / 7739 | |
|
(HPO:0002205) | Recurrent respiratory infections | Frequent [IBIS] Frequent [Orphanet] | 24049434; 18154657; 17940554 | IBIS | 254 / 7739 | |
|
(HPO:0006510) | Chronic obstructive pulmonary disease | 17594715; 23652376; 17940554 | IBIS | 19 / 7739 | ||
|
(HPO:0002099) | Asthma | Frequent [Orphanet] | 18154657; 9409865 | IBIS | 62 / 7739 | |
|
(HPO:0002791) | Hypoventilation | 18154657 | IBIS | 10 / 7739 | ||
|
(HPO:0012387) | Bronchitis | 18154657 | IBIS | 8 / 7739 | ||
|
(HPO:0002090) | Pneumonia | 9066877 | IBIS | 59 / 7739 | ||
|
(HPO:0002093) | Respiratory insufficiency | Frequent [Orphanet] | 26229500 | IBIS | 410 / 7739 | |
|
(HPO:0006532) | Recurrent pneumonia | 17594715; 18154657; 17940554 | IBIS | 48 / 7739 | ||
|
(HPO:0002098) | Respiratory distress | Frequent [Orphanet] | 8636816 | IBIS | 75 / 7739 | |
|
(HPO:0002716) | Lymphadenopathy | 9409865 | IBIS | 129 / 7739 | ||
|
(HPO:0003808) | Abnormal muscle tone | 9409865 | IBIS | 3 / 7739 | ||
|
(HPO:0003326) | Myalgia | 17940554 | IBIS | 143 / 7739 | ||
|
(HPO:0009125) | Lipodystrophy | Occasional [Orphanet] | 23188138 | IBIS | 54 / 7739 | |
|
(HPO:0012819) | Myocarditis | 9663233 | IBIS | 4 / 7739 | ||
|
(HPO:0030348) | Increased circulating androgen level | 26229500; 22876109; 18154657; 8636816; 17940554 | IBIS | 8 / 7739 | ||
|
(HPO:0002878) | Respiratory failure | 9066877 | IBIS | 57 / 7739 | ||
|
(MedDRA:10057501) | Right atrial hypertrophy | 8636816 | IBIS | 2 / 7739 | ||
|
(MedDRA:10065954) | Stubbornness | 26441796 | IBIS | 5 / 7739 | ||
|
(MedDRA:10022478) | Insulin C-peptide increased | 23652376 | IBIS | 2 / 7739 | ||
|
(HPO:0030652) | Vitreous haze | 9409865 | IBIS | 1 / 7739 | ||
|
(HPO:0012786) | Recurrent cystitis | 17940554 | IBIS | 1 / 7739 | ||
|
(OMIM) | Left ventricular dilation | 8636816 | IBIS | 13 / 7739 | ||
|
(MedDRA:10001052) | Acute respiratory distress syndrome | 17594715; 17940554 | IBIS | 3 / 7739 | ||
|
(HPO:0012795) | Abnormality of the optic disc | 2231654; 24049434 | IBIS | 187 / 7739 | ||
|
(HPO:0030084) | Clinodactyly | 22876109 | IBIS | 90 / 7739 | ||
|
(MedDRA:10017693) | Gamma-glutamyltransferase increased | 23652376; 23188138; 9066877; 9663233; 17940554 | IBIS | 2 / 7739 | ||
|
(HPO:0012813) | Unilateral breast hypoplasia | 22876109 | IBIS | 2 / 7739 |
Associated genes:
ALMS1; |
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|---|---|---|
ALMS1 | rs193919338 | pathogenic | RCV000004176.3 |
ALMS1 | rs193919339 | pathogenic | RCV000004180.3 |
ALMS1 | rs193919340 | pathogenic | RCV000004181.3 |
ALMS1 | rs387906312 | pathogenic | RCV000004177.4 |
ALMS1 | rs387906313 | pathogenic | RCV000004178.3 |
ALMS1 | rs397514576 | pathogenic | RCV000032964.3 |
ALMS1 | rs770558150 | pathogenic | RCV000194023.1 |
ALMS1 | rs772136379 | likely pathogenic | RCV000192391.1 |
ALMS1 | rs772624348 | pathogenic | RCV000192879.1 |
ALMS1 | rs797045228 | pathogenic | RCV000194605.1 |
Additional Information:
Description: (OMIM) |
Alstrom syndrome is an autosomal recessive disorder characterized by progressive cone-rod dystrophy leading to blindness, sensorineural hearing loss, childhood obesity associated with hyperinsulinemia, and type 2 diabetes mellitus. Dilated cardiomyopathy occurs in approximately 70% of patients during infancy ... |
Clinical Description OMIM |
Although this disorder bears many similarities (retinitis pigmentosa, deafness, obesity, and diabetes mellitus) to the Bardet-Biedl syndrome (209900), there is no mental defect, polydactyly, or hypogonadism (Alstrom et al., 1959). The retinal lesion causes nystagmus and early loss ... |
Molecular genetics OMIM |
Collin et al. (1999) excluded the transforming growth factor-alpha gene (190170) as a candidate for Alstrom syndrome. In affected members of 6 unrelated families with Alstrom syndrome, Collin et al. (2002) identified homozygous or compound heterozygous ... |
Diagnosis GeneReviews |
The diagnosis of Alström syndrome is based on cardinal clinical features that emerge throughout infancy, childhood, and young adulthood (see Table 1 and Figure 1).... Age RangeDiagnostic CriteriaOther Variable Supportive EvidenceMajor Minor Minimum RequiredBirth - 2 yrs 1• ALMS1 mutation in 1 allele AND/OR • Family history of Alström syndrome • Vision (nystagmus, photophobia) | • Obesity
Clinical Description GeneReviews | A wide range of clinical variability is observed among individuals with Alström syndrome, including among sibs [Hoffman et al 2005]. The first clinical presentation of Alström syndrome (Table 3) is usually nystagmus caused by cone-rod dystrophy and resulting in childhood blindness. Disease characteristics that are later in onset include truncal obesity that manifests during the first year of life, progressive sensorineural hearing loss, infantile-onset dilated cardiomyopathy or later-onset restrictive cardiomyopathy, insulin-resistant type 2 diabetes mellitus, and hepatic, pulmonary, and renal dysfunction.... FeatureAge of Onset Range (Mean)IncidenceCone-rod dystrophy | Birth - 15 mos (5 mos)100%ObesityBirth - 5 years (2.5 yrs)98%Progressive sensorineural hearing loss2-25 yrs (9 yrs)88%Dilated cardiomyopathy2 wks - 4 mos42%Restrictive cardiomyopathyJuvenile - late 30s18%Insulin resistance / type 2 diabetes mellitus4-30 yrs / 8-40 yrs (16 yrs)92% / 68%Developmental delayBirth-adolescence25%-30%Short staturePuberty - adult98%Hypogonadotropic hypogonadism10+ yrs78% of malesUrologic diseaseAdolescence - adult48%Renal diseaseAdolescence - adultVariably progressive with age in all individualsHepatic disease8-30 yrs23%-92%Based on a study of 182 patients by Marshall et al [2005]Cone-rod dystrophy. In most affected individuals, visual problems present as progressive cone dystrophy resulting in visual impairment, photophobia, and nystagmus between birth and age 15 months. Full-field electroretinography (ERG), required to establish the diagnosis of cone-rod dystrophy, is abnormal from birth, eventually with impairment of both cone and rod function. Rod function is preserved initially but deteriorates as the individual ages, with visual acuity of 6/60 or less by age ten years, increasing constriction of visual fields, and no light perception by age 20 years. In some rare cases, some vision (e.g., the ability to read large print) is retained into the third decade. The severity and age of onset of the retinal degeneration vary among affected individuals [Malm et al 2008].Fundus examination in the first decade may be normal or may show a pale optic disc and narrowing of the retinal vessels. Posterior subcapsular cataracts are common, even in the absence of diabetes. Obesity. Children with Alström syndrome have normal birth weight. Hyperphagia and excessive weight gain (some studies show weight gain greater than expected for intake) begin during their first year, resulting in childhood truncal obesity. In some individuals body weight tends to normalize, decreasing into the high-normal to normal range after adolescence. The degree of obesity may mirror cultural background, with higher levels in North America than in South America, Turkey, Japan, and parts of Europe [Koc et al 2006].Progressive bilateral sensorineural hearing loss. Hearing loss may be detected as early as age one year, initially in the high frequency range. Progressive sensorineural hearing loss presents in the first decade in as many as 70% of individuals with Alström syndrome. Hearing loss may progress to the severe or moderately severe range (40-70 db) by the end of the first to second decade [van den Abeele et al 2001]. A high incidence of glue ear (long-standing sticky fluid in the middle ear) can lead to an additional conductive hearing loss [Marshall et al 2005]. Cardiomyopathy. More than 60% of individuals with Alström syndrome develop congestive heart failure as a result of cardiomyopathy at some stage of their lives. Onset, progression, and clinical outcome of the cardiomyopathy vary, even within families [Makaryus et al 2003, Hoffman et al 2005]. More than 40% of affected infants have a transient but severe dilated cardiomyopathy with onset between age three weeks and four months [Marshall et al 2005]. Most of these children survive and make an apparently full recovery in infancy. At a later age about 10%-15% of this group have spontaneous recurrence of a progressive restrictive cardiomyopathy. The proportion of those with Alström syndrome who develop infantile-onset cardiomyopathy may be underestimated because some infants who succumb may have undiagnosed Alström syndrome.About 20% of individuals with Alström syndrome have later-onset progressive restrictive cardiomyopathy identified between the teens to late 30s. Postmortem myocardial fibrosis has been described [Marshall et al 2005]. Cardiac magnetic resonance imaging suggests that myocardial fibrosis may be present in clinically affected and asymptomatic individuals [Loudon et al 2009]. Insulin resistance/type 2 diabetes mellitus. Diabetes mellitus in Alström syndrome is the result of tissue resistance to the actions of insulin, as demonstrated by an elevated plasma insulin concentration and glucose intolerance that usually present in childhood. The age at which type 2 diabetes mellitus develops varies; it may be as early as age five years. Type 2 diabetes mellitus and insulin resistance are typically accompanied by the skin changes of acanthosis nigricans, i.e., velvety hyperpigmented patches in intertriginous areas.In a small study of 12 unrelated individuals with Alström syndrome, obesity (BMI and waist circumference) decreased with age, whereas insulin resistance increased with age [Minton et al 2006].Coronary artery disease as a result of insulin resistance, diabetes, dyslipidemia, and renal failure has been reported in one affected individual [Jatti et al 2012]. Diabetic peripheral neuropathy with risk of foot ulceration (which would be expected to develop) has been found to occur rarely if at all [Paisey et al 2009].Hyperlipidemia. Hyperlipidemia is primarily hypertriglyceridemia, but can sometimes include high serum concentration of total cholesterol. Affected individuals are at risk for sudden increase in triglycerides precipitating life-threatening pancreatitis [Wu et al 2003]. Developmental delay. About 20% of affected individuals have delay in early developmental milestones including delays in gross and fine motor skills and in expressive and receptive language. About 30% have a learning disability. Cognitive impairment (IQ <70) is very rare. Short stature. Growth rates for young children are normal, but accelerated skeletal maturity (2-3 years advanced bone age) and low-serum growth hormone concentrations result in adult stature that is typically less than the 25th centile. In about 98% of individuals over age 16 years height is below the fifth centile [Maffei et al 2007]. Scoliosis or kyphosis, beginning in puberty, is common [Maffei et al 2002].Male pubertal development. There is a variable mixture of hypogonadotropic hypogonadism and testicular fibrosis which can result in delayed or arrested puberty. As a result secondary sexual characteristics may be normal or immature; gynecomastia may be present [Marshall et al 2005]. This mixed causality has meant that puberty is induced and androgenization maintained with testosterone rather than gonadotropins. Male fertility has not been systematically studied in the syndrome but has not been reported in an affected individual with pathologic mutations in both copies of ALMS1.Female pubertal development. Endocrine disturbances in females include reduced plasma gonadotropin concentrations, hirsutism, polycystic ovarian syndrome consistent with insulin resistance, precocious puberty (pubertal onset before age 8 years), endometriosis, irregular menses, or amenorrhea. External genitalia are normal in females, though breast development is often poor. Fertility in females has not been systematically studied. Although a molecular diagnosis was not confirmed, one clinical report describes two unrelated females with late presentation of the syndrome, each of whom had healthy children [Iannello et al 2004]. Urologic disease. Urinary problems affect approximately 50% of individuals with Alström syndrome. Urologic disorders of varying severity, characterized by detrusor-urethral dyssynergia (lack of coordination of bladder and urethral muscle activity), have been described. The greatest problems appear to occur in females in their late teens. Minor symptoms include urgency and long intervals between voiding, which suggests a decrease in bladder sensation, hesitancy, and poor urinary flow. Moderate symptoms include urinary frequency, incontinence, and symptoms associated with recurrent infections. More severe urinary symptoms include worsening urinary incontinence or retention; these symptoms may alternate. Lower abdominal and perineal pain is common and may relate to abnormal bladder/sphincter function [MacDermott 2001]. Intermittent self-catheterization has been helpful in a small number of affected individuals and cystectomy with an ileal conduit has been performed in isolated severe cases.Renal disease is common, slowly progressive, and highly variable, and may be unrelated to diabetes; it manifests as tubulo-interstitial disease resulting from interstitial fibrosis. Initial signs of mildly elevated serum concentrations of creatinine and blood urea nitrogen (BUN) may be followed by polyuria and polydipsia resulting from a concentrating defect. Onset can be in mid-childhood through adulthood. End-stage renal disease (ESRD) can occur as early as the mid- to late teens.Renal biopsy often shows interstitial fibrosis, glomerular hyalinosis, and tubular atrophy [Marshall et al 2005].Obstructive uropathy is rare. Hepatic disease. Elevated plasma concentration of liver enzymes is common in early childhood. Macrovesicular steatosis and hepatomegaly can be present or absent. Progression to cirrhosis and hepatic failure can occur in the second to third decades, and the complications of portal hypertension, ascites, splenomegaly, hepatic encephalopathy, and esophageal varices are also seen. Liver biopsies and postmortem examination have revealed varying degrees of steatohepatitis, hepatic fibrosis, cirrhosis, chronic nonspecific active hepatitis with lymphocytic infiltration, patchy necrosis, and fatty liver [Quiros-Tejeira et al 2001, Marshall et al 2005].Gastrointestinal disease. General GI disturbances such as epigastric pain and gastroesophageal reflux disease (GERD) are common. Cecal volvulus without adhesions or obstructive lesions was reported in a sibling pair, raising the possibility of a generalized smooth muscle dysfunction in the syndrome [Khoo et al 2009].Pulmonary involvement. Recurrent chest infections are common at all ages, but establishment of COPD is problematic because of difficulty in accurate performance of spirometry. Most frequently there is a combination of restrictive lung disease due to kyphoscoliosis and sometimes pulmonary fibrosis, which has been confirmed in post mortem tissue and may be detected in life with high-resolution chest CT scan. This may progress (with the added effects of cardiomyopathy) to pulmonary hypertension. The resulting susceptibility to severe hypoxia postoperatively or during episodes of pneumonia has been reported [Khoo et al 2009, Florentzson et al 2010].Other Scoliosis and kyphosis of varying severity are reported in 30%-70% of individuals with Alström syndrome [van den Abeele et al 2001, Marshall et al 2005]. Severe flat feet and dental abnormalities have been observed [Koray et al 2001, Marshall et al 2005]. Hypothyroidism has been reported in nearly 20% of individuals [Marshall et al 2005]; hyperthyroidism occurs infrequently [Ozgül et al 2007]. Hypertension, often beginning in childhood, has been described in 30% of individuals [Marshall et al 2005].Neurobehavioral manifestations such as absence seizures, excessive startle response, severe and unexplained peripheral pain, and mild autistic spectrum behaviors have been reported [Marshall et al 2005].
Genotype-Phenotype Correlations GeneReviews | In one study involving fewer than 12 kindreds, no correlations were found between mutation positions and the occurrence of specific clinical features, such as dilated cardiomyopathy [Minton et al 2006].... |
Differential Diagnosis GeneReviews | Bardet-Biedl syndrome (BBS) shares some features of Alström syndrome. The major clinical features of BBS are rod-cone dystrophy, postaxial polydactyly, central obesity, cognitive impairment, hypogonadism, and renal dysfunction [Goldstone & Beales 2008]. A major difference between Alström syndrome and BBS is the timing of the onset of visual problems: in Alström syndrome, visual problems are usually apparent in the first two years of life; in BBS, the average age of onset of visual problems is 8.5 years. Polydactyly, which is common in BBS, has not been described in Alström syndrome. Cognitive impairment is well described in BBS, while in most persons with Alström syndrome intelligence is normal, but delays in early milestones have been reported. Other differences include the relative infrequency of hearing problems (~5%) and diabetes mellitus (5%-10%) in BBS compared with Alström syndrome. Mutations in at least 14 different genes are causative. Inheritance is autosomal recessive. ... |
Management GeneReviews | To establish the extent of disease in an individual diagnosed with Alström syndrome, a complete history of disease should direct detailed physical examination and investigations. A multidisciplinary team should be established to formulate and coordinate monitoring, management, and therapeutic interventions.... |
Molecular genetics GeneReviews |
Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. —ED.... Gene SymbolChromosomal LocusProtein NameLocus SpecificHGMDALMS12p13 | Alstrom syndrome protein 1Leeds Mutation Database